Publicaciones Científicas
Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma
Carrasco-Leon, A; Ezponda, T; Meydan, C; Valcarcel, LV; Ordonez, R; Kulis, M; Garate, L; Miranda, E; Segura, V; Guruceaga, E; Vilas-Zornoza, A; Alignani, D; Pascual, M; Amundarain, A; Castro-Labrador…
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis
Palladini, G; Paiva, B; Wechalekar, A; Massa, M; Milani, P; Lasa, M; Ravichandran, S; Krsnik, I; Basset, M; Burgos, L; Nuvolone, M; Lecumberri, R; Foli, A; Puig, N; Sesta, MA; Bozzola, M; Cascino, P;…
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Goicoechea, I; Puig, N; Cedena, MT; Burgos, L; Cordon, L; Vidriales, MB; Flores-Montero, J; Gutierrez, N; Calasanz, MJ; Ramos, MLM; Lara-Astiaso, D; Vilas-Zornoza, A; Alignani, D; Rodriguez, I;…
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group
Ocio, EM; Motllo, C; Rodriguez-Otero, P; Martinez-Lopez, J; Cejalvo, MJ; Martin-Sanchez, J; Blad, J; Garcia-Malo, MD; Dourdil, MV; Garcia-Mateo, A; de Arriba, F; Garcia-Sanz, R; de la Rubia, J; Oriol…
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Cuenca, I; Alameda, D; Sanchez-Vega, B; Gomez-Sanchez, D; Alignani, D; Lasa, M; Onecha, E; Lecumberri, R; Prosper, F; Ocio, EM; Gonzalez, ME; de Coca, AG; de la Rubia, J; Gironella, M; Palomera, L;…
Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project
Sargas, C; Ayala, R; Chillon, MC; Larrayoz, MJ; Carrillo-Cruz, E; Bilbao, C; Yebenes-Ramirez, M; Llop, M; Rapado, I; Garcia-Sanz, R; Vazquez, I; Soria, E; Florido-Ortega, Y; Janusz, K; Botella, C;…
Outcome of older (>= 70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study (vol 34, pg 2333, 2020)
Kayser, S; Rahme, R; Martinez-Cuadron, D; Ghiaur, G; Thomas, X; Sobas, M; Guerci-Bresler, A; Garrido, A; Pigneux, A; Gil, C; Raffoux, E; Tormo, M; Vey, N; de la Serna, J; Salamero, O; Lengfelder, E;…
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
Ribera, JM; Morgades, M; Coll, R; Barba, P; Lopez-Lorenzo, JL; Montesinos, P; Foncillas, MA; Cabrero, M; Gomez-Centurion, I; Morales, MD; Varela, MR; Herrera, P; Garcia-Cadenas, I; Calbacho, M;…
Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
Castano-Bonilla, T; Alonso-Dominguez, JM; Barragan, E; Rodriguez-Veiga, R; Sargas, C; Gil, C; Chillon, C; Vidriales, MB; Garcia, R; Martinez-Lopez, J; Ayala, R; Larrayoz, MJ; Anguita, E; Cuello, R;…
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants
Cicconi, L; Testi, AM; Montesinos, P; Rego, E; Zhu, HH; Takahashi, H; Dworzak, M; Estey, E; Schwarer, A; Esteve, J; Annibali, O; Castelli, R; Mirabile, M; Angelini, M; Lazarevic, V; Kumar, J;…